great
interest
demand
develop
vaccin
prevent
treat
divers
microbi
infect
mucos
vaccin
elicit
immun
protect
stimul
product
antibodi
mucos
surfac
system
district
posit
close
proxim
larg
commun
commens
microb
mucos
immun
system
deploy
heterogen
popul
cell
complex
regulatori
network
maintain
balanc
surveil
toler
success
mucos
vaccin
reli
leverag
function
immun
cell
regulatori
compon
review
import
cellular
interact
molecular
pathway
underli
induct
regul
mucos
antibodi
respons
discuss
implic
mucos
vaccin
infect
caus
mani
old
emerg
reemerg
pathogen
mycobacterium
tuberculosi
vibrio
cholera
aspergillu
fumigatu
helminth
coxsacki
viru
influenza
virus
rhinoviru
sever
acut
respiratori
syndrom
sar
coronaviru
human
immunodefici
viru
hiv
pose
sever
health
problem
world
popul
great
challeng
realiz
millennium
develop
goal
outlin
unit
nation
millennium
declar
health
problem
particularli
seriou
peopl
live
develop
countri
area
poor
hygien
peopl
condit
caus
compromis
immun
although
effect
antibiot
avail
bacteri
fungal
parasit
pathogen
drug
applic
diseas
prevent
give
rise
insidi
trend
drug
resist
prolong
use
addit
approv
antivir
drug
highli
effect
mani
viral
pathogen
coxsacki
viru
rhinoviru
sar
coronaviru
vaccin
work
stimul
immun
system
combat
infect
appear
promis
muchneed
approach
treatment
prevent
diseas
common
featur
infect
caus
divers
type
pathogen
usual
occur
initi
mucos
surfac
ampl
evid
exist
system
vaccin
adequ
offer
protect
select
pathogen
polio
influenza
virus
haan
et
al
herreman
et
al
increas
number
studi
shown
induct
mucos
immun
requir
effect
protect
import
pathogen
hiv
human
papillomaviru
herp
virus
vibrio
cholera
mycobacterium
speci
belyakov
et
al
chen
et
al
gallichan
rosenth
neutra
kozlowski
wang
et
al
addit
superior
abil
mucos
vaccin
induc
local
mucos
immun
respons
system
vaccin
neutra
kozlowski
mucos
vaccin
also
offer
mani
logist
addit
immunolog
advantag
system
vaccin
simpli
ingest
inhal
vaccin
mucos
vaccin
requir
inject
caus
less
pain
thu
high
complianc
among
patient
age
simplifi
manufactur
storag
method
well
independ
train
medic
personnel
deliveri
make
mucos
vaccin
suitabl
mass
vaccin
program
especi
develop
countri
emerg
mucos
immun
system
access
induct
immun
respons
mucos
surfac
principl
act
site
antigen
entri
importantli
mucos
vaccin
target
specif
mucos
district
induc
frontlin
immun
site
pathogen
entri
prevent
establish
dissemin
infect
addit
immun
one
mucos
site
result
antibodi
secret
system
well
select
mucos
site
holmgren
czerkinski
howev
dozen
mucos
vaccin
current
approv
human
use
holmgren
czerkinski
constitut
embarrass
contrast
sever
health
problem
pose
mucos
pathogen
mani
advantag
mucos
vaccin
situat
result
larg
numer
immunolog
technolog
challeng
confront
quest
success
mucos
vaccin
success
mucos
vaccin
abl
penetr
mucos
barrier
right
mucos
district
control
manner
induc
innat
adapt
immun
respons
activ
dendrit
cell
dc
macrophag
epitheli
cell
ec
innat
immun
system
well
antigenspecif
effector
memori
b
cell
adapt
immun
system
cooper
one
anoth
achiev
optim
potenc
durat
protect
holmgren
czerkinski
achiev
goal
adjuv
frequent
requir
see
coffman
et
al
improp
mucos
vaccin
formul
caus
poor
absorpt
limit
bioavail
high
rate
mucos
enzymemedi
inactiv
mucos
clearanc
may
lead
deliveri
vaccin
improp
mucos
district
target
wrong
mucos
cell
type
holmgren
czerkinski
addit
delic
dynam
immunolog
balanc
maintain
mucos
surfac
result
presenc
larg
number
commens
flora
success
mucos
vaccin
must
simultan
evok
mucos
respons
avoid
mucos
inflamm
toler
system
vaccin
deliv
known
dose
antigen
bodi
gener
readili
measur
humor
cellmedi
respons
dose
mucos
vaccin
enter
bodi
difficult
measur
accur
efficaci
mucos
vaccin
also
difficult
determin
difficulti
captur
quantit
antibodi
mucos
secret
technic
challeng
determin
function
divers
mucos
cell
subset
neutra
kozlowski
mention
earlier
mucos
immun
involv
intim
interplay
innat
adapt
immun
system
complex
web
cellular
signal
network
thu
vaccin
expect
achiev
optim
respons
leverag
interact
innat
adapt
compon
mucos
immun
system
articl
review
current
knowledg
cellular
molecular
pathway
underli
mucos
antibodi
respons
mucos
homeostasi
discuss
implic
knowledg
design
effect
mucos
vaccin
malt
mucosaassoci
lymphoid
tissu
includ
nasopharynxassoci
lymphoid
tissu
nalt
bronchusassoci
lymphoid
tissu
balt
gutassoci
lymphoid
tissu
galt
compris
peyer
patch
pp
isol
lymphoid
follicl
ilf
human
gener
anatom
welldefin
nalt
except
earli
age
possess
oropharyng
lymphoid
tissu
pharyng
tubal
palatin
lingual
tonsil
set
lymphat
tissu
call
waldey
ring
may
constitut
human
equival
mous
nalt
kiyono
fukuyama
kunisawa
et
al
conjunctivaassoci
lymphoid
tissu
calt
lacrim
ductassoci
lymphoid
tissu
ldalt
larynxassoci
lymphoid
tissu
lalt
salivari
ductassoci
lymphoid
tissu
sdalt
also
describ
human
gebert
pabst
segment
malt
compris
anatom
function
distinct
induct
effector
site
induct
site
includ
mucosaassoci
follicl
intestin
pp
ifl
mesenter
lymph
node
antigenspecif
b
cell
undergo
activ
clonal
expans
differenti
b
effector
cell
cell
migrat
induct
site
effector
site
carri
effector
function
effector
site
present
mucos
district
nonorgan
lymphoid
tissu
diffus
distribut
throughout
lamina
propria
lp
kiyono
fukuyama
kunisawa
et
al
cytotox
lymphocyt
ctl
lyse
infect
cell
b
cell
differenti
plasma
cell
secret
larg
amount
immunoglobulin
iga
predomin
antibodi
isotyp
intestin
secret
togeth
igm
respiratori
urogenit
secret
also
contain
igg
igd
two
antibodi
isotyp
less
defin
mucos
function
iga
igm
transport
across
ec
polymer
ig
receptor
pigr
wherea
igg
transport
across
ec
neonat
fc
receptor
roja
apodaca
antibodi
transport
util
igd
unknown
chen
cerutti
malt
gener
immun
architectur
resembl
system
lymphoid
tissu
includ
presenc
b
cellrich
follicl
cellrich
interfollicular
area
howev
malt
also
sever
uniqu
anatom
cellular
featur
inde
galt
nalt
provid
effer
affer
lymphat
therefor
sampl
exogen
antigen
directli
mucos
surfac
brandtzaeg
et
al
addit
galt
nalt
harbor
highli
heterogen
popul
immun
cell
establish
intim
interact
ec
regard
pp
cap
follicleassoci
epithelium
equip
microfold
membran
cell
cell
special
antigen
sampl
similar
cell
present
crypt
tonsil
adenoid
owe
short
microvilli
thin
mucu
layer
abund
cytoplasm
vesicl
effici
transcytosi
activ
cell
effect
take
lumen
antigen
transfer
neighbor
antigenpres
cell
apc
neutra
et
al
gener
malt
contain
complex
network
apc
differenti
modul
mucos
immun
respons
apc
includ
multipl
dc
subset
popul
specif
region
malt
perform
distinct
function
helft
et
al
iwasaki
iwasaki
pulendran
varol
et
al
review
see
palucka
et
al
dc
express
cx
c
chemokin
receptor
cx
involv
process
present
antigen
initi
adapt
cell
respons
varol
et
al
wherea
dc
express
e
b
integrin
condit
local
cell
gener
regulatori
treg
cell
cell
subset
pivot
maintain
mucos
immun
toler
homeostasi
coomb
et
al
jaensson
et
al
phenotyp
nalt
dc
clearli
determin
human
tonsillar
dc
compris
heterogen
group
immatur
dc
reticular
epithelium
crypt
matur
dc
interfollicular
region
dieu
et
al
xu
et
al
xu
et
al
function
differ
among
dc
subset
remain
investig
addit
dc
malt
contain
mani
cell
type
potenti
antigenpres
regulatori
function
macrophag
den
et
al
smythi
et
al
role
cell
regul
mucos
antibodi
product
immun
homeostasi
begin
understood
mucos
immun
system
act
independ
system
immun
system
kiyono
fukuyama
although
anatom
separ
differ
region
malt
function
connect
term
common
mucos
immun
system
permit
cell
b
cell
activ
antigen
one
specif
mucos
site
appear
effector
cell
b
cell
distant
mucos
site
kiyono
fukuyama
function
connect
achiev
induct
specif
set
mucos
home
receptor
interact
b
cell
mucos
dc
exampl
oral
intranas
immun
stimul
effector
b
cell
respons
distant
mucos
tissu
intestin
urogenit
tract
spite
function
connect
nalttarget
immun
preferenti
induc
antigenspecif
immun
respiratori
reproduct
tissu
wherea
galttarget
immun
predominantli
elicit
protect
respons
gastrointestin
tissu
support
compartment
common
mucos
immun
system
deriv
evid
indic
nasal
immun
induc
igaproduc
b
cell
express
cc
chemokin
receptor
b
integrin
bind
b
cc
chemokin
ligand
vascular
cell
adhes
respect
mediat
traffick
igaproduc
b
cell
respiratori
genitourinari
tract
lazaru
et
al
contrast
oral
immun
stimul
igaproduc
b
cell
express
chemokin
receptor
well
b
b
integrin
lazaru
et
al
bind
b
b
mucos
vascular
addressin
cell
adhes
respect
permit
igaproduc
b
cell
home
small
intestin
mora
et
al
exampl
highlight
exist
subtl
differ
common
mucos
immun
system
may
result
exposur
anatom
distinct
mucos
site
differ
popul
microorgan
import
vaccin
develop
realiz
region
mucos
immun
system
differ
pp
lp
enorm
potenti
complement
function
one
anoth
develop
mucos
antibodi
respons
although
iga
constitut
predomin
class
mucos
antibodi
multipl
layer
antibodi
respons
compris
sever
antibodi
isotyp
place
ensur
frontlin
surveil
mucos
surfac
reflect
mark
increas
igmand
iggsecret
b
cell
galt
igd
igg
igmsecret
b
cell
nalt
subject
select
iga
defici
brandtzaeg
et
al
may
explain
frequent
asymptomat
natur
primari
immunodefici
human
cunninghamrundl
mice
mbawuik
et
al
must
also
note
human
two
iga
iga
isotyp
distinct
regul
function
anatom
distribut
mice
one
iga
isotyp
cerutti
underli
multipl
layer
antibodi
respons
collabor
mechan
follicular
extrafollicular
machineri
involv
celldepend
cellindepend
pathway
mucos
b
cell
activ
chen
et
al
cong
et
al
fagarasan
et
al
et
al
tsuji
et
al
tsuji
et
al
impli
mucos
vaccin
effici
respons
initi
synergist
target
multipl
compon
complex
b
cellactiv
pathway
matur
b
cell
acquir
iga
express
undergo
delet
dna
recombin
event
call
class
switch
recombin
csr
take
place
chromosom
contain
recombin
ig
heavi
h
chain
locu
cerutti
matur
b
cell
igh
locu
includ
recombin
v
h
dj
h
exon
encod
antigenbind
variabl
region
antibodi
multipl
set
constant
h
chain
c
h
exon
encod
c
c
c
g
c
c
region
antibodi
stavnez
et
al
c
h
region
account
effector
function
antibodi
c
region
critic
transport
antibodi
across
ec
cerutti
rescigno
csr
igm
iga
involv
exchang
upstream
donor
c
gene
downstream
acceptor
c
gene
delet
interven
c
h
gene
cerutti
csr
guid
promot
posit
upstream
genet
unit
compris
short
intron
exon
switch
region
c
h
gene
stavnez
et
al
select
iga
csr
achiev
specif
cytokin
signal
initi
transcript
promot
germlin
transcript
allow
csr
machineri
stavnez
et
al
includ
dnaedit
enzym
activationinduc
cytidin
deaminas
aid
target
region
introduc
doublestrand
dna
break
chaudhuri
alt
muramatsu
et
al
subsequ
join
break
dna
repair
machineri
result
intrachromosom
delet
interven
sequenc
juxtaposit
downstream
c
gene
upstream
v
h
dj
h
exon
encod
antigenbind
v
region
allow
express
fulllength
iga
aid
also
mediat
affin
matur
introduc
highrat
somat
point
mutat
vdj
exon
produc
highaffin
iga
antibodi
honjo
et
al
muramatsu
et
al
iga
classswitch
b
cell
differenti
plasmablast
plasma
cell
secret
iga
appropri
cytokin
environ
cerutti
rescigno
macpherson
et
al
understand
signal
regul
iga
csr
product
critic
design
effect
vaccin
boost
mucos
iga
respons
galt
antibodi
respons
strongli
bias
toward
iga
involv
activ
follicular
b
cell
antigen
cell
express
ligand
macpherson
et
al
igaproduc
b
cell
emerg
germin
center
gc
pp
mesenter
lymph
node
organ
lymphoid
structur
contain
cellular
composit
cytokin
environ
conduc
iga
csr
product
figur
particular
pp
b
cell
ratio
four
six
time
higher
peripher
lymph
node
steven
et
al
engag
b
cell
cell
recruit
tumor
necrosi
factor
receptorassoci
factor
traf
protein
activ
nuclear
factorkb
nfkb
pathway
induc
express
aid
essenti
requir
iga
csr
cerutti
second
seemingli
essenti
requir
iga
csr
pp
transform
growth
cytokin
produc
treg
cell
follicular
helper
tfh
cell
produc
cell
dc
stromal
cell
b
cell
perhap
also
ec
barn
powri
cong
et
al
fagarasan
et
al
fillatreau
et
al
maynard
et
al
strober
tsuji
et
al
play
pivot
role
promot
iga
csr
induc
nuclear
transloc
mother
decapentapleg
smad
protein
runtrel
transcript
factor
cyclic
amp
respons
element
bind
protein
creb
cooper
initi
germlin
c
gene
transcript
cerutti
mice
b
cellspecif
defici
tgfb
receptor
type
ii
downstream
signal
protein
show
profound
defici
steadyst
antigeninduc
iga
system
galt
cazac
roe
pp
also
contain
cytokin
promot
expans
iga
classswitch
b
cell
differenti
igasecret
plasma
cell
cerutti
addit
pp
ilf
constitut
anoth
induct
site
iga
csr
product
fagarasan
honjo
fagarasan
et
al
contribut
ilf
gener
iga
demonstr
use
retino
acidrel
orphan
receptorgt
rorgt
encod
rora
gene
defici
mice
pp
ilf
instrument
role
rorgt
lymphoid
tissu
induc
lti
cell
induct
structur
tsuji
et
al
adopt
transfer
rorgt
lti
cell
rora
mice
result
format
ilf
pp
appear
mani
iga
b
cell
ilf
tsuji
et
al
interestingli
activ
iga
csr
ilf
requir
help
b
cell
cell
tsuji
et
al
howev
ilf
probabl
contribut
steadyst
iga
product
commens
flora
margin
role
antigenspecif
iga
product
respons
mucos
immun
mice
treat
utero
solubl
tnf
decoy
receptor
solubl
lymphotoxin
b
ltb
decoy
receptor
two
compound
abrog
format
pp
mesenter
lymph
node
ilf
fail
develop
antigenspecif
iga
respons
oral
immun
despit
unalt
intestin
iga
antibodi
yamamoto
et
al
interestingli
b
cell
pp
undergo
iga
csr
antigenspecif
iga
product
without
requir
express
somat
recombin
antigen
ig
receptor
casola
et
al
usual
need
intern
present
antigen
cell
context
cognat
bt
cell
interact
instead
b
cell
pp
heavili
reli
germlin
geneencod
innat
antigen
receptor
known
tolllik
receptor
tlr
mount
iga
respons
least
mice
casola
et
al
tlr
initi
innat
adapt
immun
respons
recogn
highli
conserv
microbi
molecular
signatur
provid
protect
mucos
infect
enhanc
iga
csr
v
j
somat
hypermut
casola
rajewski
delgado
et
al
cell
pp
sampl
commens
vaccin
antigen
intestin
lumen
deliv
subepitheli
dc
antigen
sampl
also
carri
cx
dc
project
dendrit
intestin
lumen
across
ec
cell
releas
immunoregulatori
tslp
igainduc
baff
april
molecul
upon
sens
microbi
signatur
tlr
nlr
tslp
stimul
format
tolerogen
dc
suppress
proinflammatori
h
respons
induc
noninflammatori
treg
respons
releas
ra
treg
cell
may
differenti
fh
cell
togeth
treg
perhap
cell
stimul
iga
csr
product
stimul
naiv
igm
igd
b
cell
presenc
ra
igaexpress
b
cell
emerg
mucos
germin
center
acquir
express
guthom
receptor
b
direct
subsequ
b
cell
migrat
intestin
lp
effer
lymphat
region
mesenter
lymph
node
blood
circul
lp
igaexpress
b
cell
differenti
igasecret
plasma
cell
secret
iga
dimer
interact
iga
dimer
pigr
result
iga
transcytosi
format
secretori
iga
siga
complex
bind
antigen
intestin
lumen
lp
also
contain
macrophag
baffaprilnitr
oxideproduc
tipdc
whose
develop
promot
microbi
epitheli
factor
tslp
tipdc
macrophag
would
enhanc
local
iga
product
trigger
csr
stimul
plasma
cell
surviv
import
oral
administ
vaccin
target
cell
pp
order
gener
effici
antigenspecif
iga
respons
neutra
kozlowski
follow
activ
csr
upregul
guthom
receptor
b
integrin
type
receptor
downregul
follicular
local
receptor
igaproduc
b
cell
migrat
induct
site
pp
effector
site
gut
lp
effer
lymphat
region
mesenter
lymph
node
gener
circul
suzuki
fagarasan
lp
igaproduc
b
cell
differenti
igasecret
plasma
cell
figur
studi
mice
human
shown
lp
also
necessari
cellular
molecular
machineri
induc
iga
csr
independ
cell
suzuki
fagarasan
absenc
pp
ilf
mesenter
lymph
node
intestin
iga
respons
gener
lp
inde
mice
defici
inhibitor
dna
bind
lta
pp
ilf
mesenter
lymph
node
retain
antigenspecif
iga
plasma
cell
lp
eberl
littman
kang
et
al
addit
protect
mucos
antibodi
respons
gener
intranas
immun
inact
influenza
viru
mice
defici
cell
sha
et
al
furthermor
human
defici
advanc
aid
patient
defici
cell
retain
intestin
iga
respons
lp
xu
et
al
find
import
implic
develop
mucos
vaccin
especi
peopl
preexist
condit
immunosuppress
transplant
diabet
patient
subject
inde
lp
contain
igm
b
cell
migrat
either
bone
marrow
pp
suzuki
et
al
b
cell
undergo
differenti
igmsecret
plasma
cell
serv
local
precursor
igaand
iggproduc
b
cell
celland
manner
fagarasan
et
al
cellindepend
antigen
initi
iga
csr
activ
multipl
innat
immun
pathway
cellindepend
antigen
microbi
lipopolysaccharid
lp
nucleic
acid
activ
b
cell
tlr
pasar
medzhitov
peng
xu
et
al
xu
et
al
wherea
cellindepend
antigen
bacteri
capsular
polysaccharid
cp
activ
b
cell
surfac
ig
receptor
mond
et
al
dc
monocyt
neutrophil
basophil
ec
stromal
cell
releas
power
iga
csrinduc
factor
b
cell
activ
factor
tnf
famili
baff
proliferationinduc
ligand
april
respons
microbi
tlr
ligand
charl
et
al
chen
et
al
gorelik
et
al
et
al
litinskiy
et
al
scapini
et
al
xu
et
al
place
innat
immun
cell
epitheli
cell
stromal
cell
promin
target
mucos
vaccin
human
iga
classswitch
b
cell
undergo
sequenti
csr
iga
iga
lp
influenc
april
express
dc
ec
process
particularli
evid
distal
portion
intestin
may
account
greater
abund
iga
found
baff
april
induc
iga
igg
csr
activ
germlin
g
transcript
aid
express
nfkb
signal
via
receptor
transmembran
activ
calcium
modul
cyclophylin
ligand
interactor
taci
adaptor
protein
myeloid
differenti
primari
respons
gene
et
al
combin
microbi
tlr
ligand
baff
april
suffici
induc
iga
product
mous
human
b
cell
tsuji
et
al
xu
et
al
suggest
exist
intim
interplay
taci
tlr
recent
find
taci
trigger
csr
via
et
al
fact
usual
associ
tlr
rais
possibl
signal
integr
taci
tlr
pathway
suggest
vaccin
formul
simultan
activ
pathway
could
superior
boost
mucos
iga
respons
human
human
one
promin
differ
respiratori
intestin
mucos
surfac
lie
immunoglobulin
composit
unlik
mice
human
substanti
percentag
igdproduc
b
cell
malt
associ
nasal
caviti
tonsil
pharynx
salivari
gland
lacrim
gland
galt
brandtzaeg
et
al
chen
et
al
chen
cerutti
possibl
igd
may
import
valu
mucos
vaccin
support
observ
percentag
igdproduc
b
cell
upper
respiratori
tract
increas
much
plasmacyt
individu
select
iga
defici
brandtzaeg
et
al
similar
human
teleost
subset
b
cell
express
igd
igm
suggest
evolutionarili
conserv
immunolog
advantag
igd
igm
chen
cerutti
remark
igd
hypermut
human
antibodi
isotyp
long
heavychain
complementaritydetermin
region
chen
cerutti
koelsch
et
al
may
form
protrud
fingerlik
structur
capabl
target
recess
neutral
viral
epitop
burton
et
al
saphir
et
al
moreov
igd
bind
mani
bacteri
virul
factor
induc
b
cellstimul
antimicrobi
program
basophil
therebi
contribut
mucos
system
antibodi
product
antimicrobi
defens
chen
cerutti
chen
et
al
similar
iga
multipl
follicular
extrafollicular
pathway
well
celldepend
cellindepend
signal
includ
baff
april
well
particip
promot
igd
csr
product
mucos
b
cell
chen
cerutti
chen
et
al
requir
baff
april
induct
igd
highlight
import
target
upper
aerodigest
mucos
tfh
cell
dc
ec
mucos
vaccin
aim
boost
igd
respons
dual
abil
igd
bind
antigen
amplifi
immun
activ
system
mucos
site
entri
may
explain
studi
nasal
rout
advantag
rout
vaccin
administr
holmgren
czerkinski
chen
cerutti
import
understand
mucos
immun
system
oper
forefront
bodi
immun
battlefield
immun
octob
elsevi
inc
immun
review
close
proxim
enorm
amount
commens
flora
deploy
multipl
type
immun
cell
organ
phenotyp
function
distinct
subset
util
intric
regulatori
signal
network
reinforc
mucos
antibodi
respons
maintain
harmoni
coexist
local
microbiota
understand
complex
regulatori
network
pivot
develop
effect
mucos
vaccin
tfh
cell
play
import
role
promot
mucos
iga
csr
iga
product
home
igacommit
b
cell
mucos
site
tfh
cell
tonsil
pp
produc
synerg
skew
csr
toward
iga
dullaer
et
al
tsuji
et
al
also
downregul
chemokin
receptor
promot
follicular
local
b
cell
upregul
chemokin
receptor
facilit
migrat
iga
classswitch
b
cell
local
mucos
effector
site
hieshima
et
al
tfh
cell
may
deriv
treg
cell
pp
upon
receiv
signal
activ
pp
b
cell
tsuji
et
al
therefor
one
predict
mucos
vaccin
robustli
promot
gener
tfh
cell
treg
cell
induc
protect
iga
product
concurr
avoid
mucos
toler
besid
tfh
cell
import
regul
mucos
follicular
antibodi
respons
also
carri
ec
dc
macrophag
treg
cell
cell
granulocyt
nk
cell
well
b
cell
ec
gatekeep
mucosa
releas
myriad
factor
respons
commens
microb
present
lumen
probabl
sens
microb
innat
immun
receptor
tlr
intracellular
nodlik
receptor
nlr
abreu
hooper
macpherson
among
import
factor
baff
april
secretori
leukocyt
proteas
inhibitor
slpi
thymic
stromal
lymphopoietin
tslp
epitheli
baff
april
promot
cellindepend
iga
csr
plasma
cell
surviv
slpi
serv
homeostat
regul
attenu
baff
signal
b
cell
xu
et
al
tslp
stimul
dc
produc
baff
april
xu
et
al
skew
cell
differenti
toward
cell
direct
repress
rimoldi
et
al
zaph
et
al
induct
ligand
ito
et
al
engend
celldomin
environ
pp
help
product
iga
subset
mucos
dc
express
also
call
e
integrin
may
bind
epitheli
adhes
molecul
ecadherin
facilit
dc
condit
ec
strober
tslpcondit
dc
also
produc
li
flavel
addit
facilit
iga
csr
cooper
dcderiv
factor
retino
acid
ra
ido
induc
develop
treg
cell
suppress
develop
proinflammatori
cell
coomb
et
al
matteoli
et
al
mucida
et
al
furthermor
cooper
induc
develop
cell
barn
powri
human
intestin
macrophag
produc
proinflammatori
cytokin
respons
inflammatori
stimuli
smythi
et
al
mous
lp
macrophag
promot
develop
treg
cell
den
et
al
mucos
cell
type
import
maintain
noninflammatori
environ
prevent
harm
immun
respons
commens
physiolog
condit
mention
earlier
treg
cell
tregderiv
tfh
cell
cell
also
import
sourc
igainduc
signal
cong
et
al
tsuji
et
al
convers
igaproduc
b
cell
precursor
may
enhanc
gener
treg
cell
cell
releas
asseman
et
al
cerutti
rescigno
fillatreau
et
al
mizoguchi
et
al
note
produc
latent
form
requir
either
proteolyt
cleavag
proregion
matrix
metalloproteinas
mmp
conform
chang
bind
certain
cellsurfac
receptor
order
convert
inact
precursor
activ
taylor
unlik
dc
system
lymph
node
mucos
dc
uniqu
express
high
level
activ
high
effici
tsuji
et
al
addit
mucos
dc
releas
ra
cooper
enhanc
iga
secret
iwata
et
al
mora
et
al
mucos
dc
would
augment
iga
product
nitric
oxid
mice
intestin
mucosa
contain
subset
dc
call
tipdc
express
tnf
induc
nitric
oxid
synthas
ino
releas
larg
amount
nitric
oxid
recogn
commens
bacteria
tlr
tezuka
et
al
nitric
oxid
enhanc
iga
csr
product
upregul
tgfbrii
express
pp
b
cell
induc
dc
express
baff
april
unknown
mechan
tezuka
et
al
mucos
nk
nkt
cell
role
innat
cell
type
mucos
immun
well
understood
sever
studi
show
contribut
mucos
homeostasi
releas
cytokin
enhanc
surviv
prolifer
antimicrobi
activ
ec
colonna
satohtakayama
et
al
vivier
et
al
zenewicz
et
al
given
broad
role
mucos
homeostasi
conceiv
cytokin
also
augment
product
igainduc
factor
ec
food
thought
mucos
immun
regul
vitamin
discuss
mani
regulatori
dc
subset
galt
produc
ra
metabol
deriv
vitamin
found
food
inde
abil
synthes
ra
limit
galt
dc
seem
broad
phenomenon
found
mani
mucos
immun
cell
lp
macrophag
den
et
al
mesenter
lymph
node
dc
coomb
et
al
pp
dc
iwata
et
al
lp
dc
uematsu
et
al
lp
tipdc
tezuka
et
al
ec
iwata
et
al
mast
cell
basophil
spiegl
et
al
promot
iga
csr
plasma
cell
differenti
treg
cell
develop
ra
appear
central
regul
intestin
immun
homeostasi
moreov
ra
central
regul
cell
b
cell
traffick
toward
effector
site
intestin
lp
ra
induc
express
gut
home
receptor
b
integrin
cell
iwata
et
al
cell
iwata
et
al
intraepitheli
lymphocyt
iel
iwata
et
al
treg
cell
benson
et
al
b
cell
mora
et
al
tezuka
et
al
gut
home
achiev
b
integrin
bind
express
endotheli
cell
postcapillari
venul
intestin
tissu
bind
chemokin
releas
ec
small
intestin
iwata
et
al
mora
et
al
ra
origin
vitamin
seri
enzymat
reaction
culmin
final
irrevers
step
catalyz
retin
dehydrogenas
peroxisom
proliferatoractiv
receptor
g
pparg
agonist
well
bacteri
flagellin
ligand
shown
activ
express
dc
elgueta
et
al
szatmari
et
al
uematsu
et
al
low
amount
signal
might
involv
mainten
basal
raldh
express
ra
product
galt
ra
diet
deriv
mucos
vaccin
strategi
encompass
stimul
ra
product
dietari
supplement
vitamin
well
induct
raldh
express
seem
appeal
explor
particularli
vaccin
trial
develop
countri
vitamin
defici
common
great
number
vaccin
studi
anim
model
human
demonstr
benefit
take
advantag
tlr
signal
system
boost
efficaci
mucos
vaccin
mbow
et
al
discuss
earlier
tlr
involv
recognit
microbi
molecular
structur
express
multipl
cell
type
mucos
immun
system
ec
dc
cell
b
cell
sens
product
commens
pathogen
microorgan
induc
express
critic
regulatori
factor
contribut
mucos
defens
homeostasi
presenc
microbi
tlr
ligand
intestin
ec
express
antimicrobi
factor
regiiig
cash
et
al
b
cellactiv
factor
baff
april
xu
et
al
immunoregulatori
factor
tslp
liu
et
al
wherea
malt
dc
express
ino
produc
nitric
oxid
tezuka
et
al
lp
dc
express
produc
ra
respons
flagellin
stimul
uematsu
et
al
b
cell
express
tlr
stimul
varieti
tlr
ligand
trigger
b
cell
prolifer
differenti
antibodi
secret
cell
antigen
present
cytokin
secret
csr
avalo
et
al
lanzavecchia
sallusto
import
pathway
vaccin
exemplifi
recent
studi
show
critic
requir
provid
tlr
stimul
directli
b
cell
order
formalininactiv
respiratori
syncyti
viru
vaccin
induc
affin
matur
confer
protect
delgado
et
al
howev
benefit
target
tlr
mucos
vaccin
come
price
administr
tlr
ligand
may
caus
inflamm
autoimmun
diseas
especi
longterm
stimul
avalo
et
al
isra
et
al
mullick
et
al
certain
tlr
ligand
may
play
pathogen
role
tumorigenesi
exist
neoplast
process
may
divert
tlr
signal
tumor
facilit
surviv
immun
evas
huang
et
al
rakoffnahoum
medzhitov
wang
et
al
imprud
therapeut
target
tlr
mucos
vaccin
caution
circumvent
potenti
advers
effect
reli
thorough
understand
respons
differ
mucos
immun
cell
type
variou
tlr
ligand
stimul
antibodi
respons
initi
mucos
induct
site
exhibit
protect
function
myriad
mechan
distinct
system
initi
counterpart
mucos
antibodi
respons
offer
critic
step
protect
host
inhibit
first
step
microbi
pathogenesi
ie
microbi
adher
mucos
ec
cerutti
rescigno
mucos
antibodi
also
inhibit
activ
mani
detriment
microbi
enzym
toxin
lumen
neutral
mucos
virus
insid
ec
cerutti
rescigno
invas
pathogen
breach
epitheli
barrier
mucos
igg
mediat
opson
intern
pathogen
phagocyt
turn
lead
activ
phagocyt
kill
pathogen
present
pathogenderiv
antigen
activ
multipl
type
mucos
effector
cell
cell
gd
cell
ctl
cell
promot
pathogen
contain
clearanc
cerutti
rescigno
mucos
antibodi
igg
iga
promot
antibodydepend
cellmedi
cytotox
adcc
nk
cell
neutrophil
eosinophil
lyse
infect
cell
nimmerjahn
ravetch
igd
recruit
basophil
aerodigest
mucosa
activ
antimicrobi
b
cellstimul
respons
directli
particip
frontlin
antimicrobi
defens
chen
et
al
ad
advantag
vaccin
boost
mucos
iga
respons
iga
mediat
apicaltobasolater
retrotranscytosi
antigen
across
cell
via
unknown
receptor
across
duoden
epitheli
cell
via
transfer
receptor
also
known
therebi
enabl
control
entri
specif
antigen
initi
mucos
immun
respons
cerutti
rescigno
retrotranscytosi
process
deliv
intact
antigen
basolater
side
ec
phalipon
sy
convers
iga
transport
invas
pathogen
breach
epitheli
barrier
back
lumen
elimin
pigrmedi
basolateraltoap
transcytosi
kaetzel
et
al
process
would
limit
amount
immun
complex
avail
lp
therebi
avoid
unnecessari
inflammatori
mucos
respons
situat
sever
infect
vaccin
target
mucos
iga
respons
addit
advantag
trigger
system
product
monomer
iga
macpherson
et
al
iga
promot
immun
protect
without
caus
detriment
system
inflamm
remov
invad
pathogen
noninflammatori
fcari
receptor
express
surfac
phagocyt
includ
neutrophil
cerutti
rescigno
pasquier
et
al
final
recent
evid
indic
secretori
iga
appeas
mucos
immun
system
close
contact
heavi
indigen
microbi
load
restrain
commens
florainduc
activ
host
oxid
system
peterson
et
al
recent
studi
intestin
immun
respons
commens
flora
yield
import
insight
dynam
mucos
antibodi
respons
reveal
novel
differ
system
antibodi
respons
commens
flora
known
orchestr
postnat
matur
mucos
immun
system
arti
macpherson
uhr
use
control
revers
intestin
colon
system
intestin
iga
respons
shown
direct
major
commens
microbi
speci
given
time
cerutti
hapfelmei
et
al
jiang
et
al
suzuki
et
al
similar
intestin
cell
respons
mainli
direct
major
segment
filament
bacteria
speci
gaboriaurouthiau
et
al
ivanov
et
al
furthermor
intestin
iga
respons
high
threshold
bacteria
elicit
iga
product
lack
classic
memori
primeboost
featur
display
constant
attrit
subsequ
challeng
differ
antigen
diminish
respons
previou
antigen
challeng
deviat
substanti
classic
system
immun
memori
paradigm
therefor
intestin
iga
respons
builtin
algorithm
total
strength
control
constantli
adapt
intestin
iga
current
microbiota
mucos
immunolog
logic
conceiv
consid
fact
abund
microbi
speci
higher
chanc
breach
epitheli
barrier
therefor
steadyst
iga
predominantli
target
speci
avoid
potenti
wast
overdiversifi
respons
great
abund
commens
bacteria
intestin
iga
respons
also
involv
high
antigen
threshold
featur
highlight
import
integr
epitheli
barrier
inde
mucos
inflamm
clonal
exhaust
immunolog
paralysi
could
ensu
abund
commens
speci
breach
epithelia
overwhelm
amount
halliday
mitchison
iga
limit
potenti
lethal
outcom
tightli
control
amount
antigen
input
across
ec
assum
mucos
immun
respons
antigen
pathogen
vaccin
follow
similar
set
principl
induct
longlast
protect
iga
respons
would
requir
use
vaccin
strategi
ensur
prolong
suppli
antigen
sustain
stimul
intestin
b
cell
strategi
could
includ
embed
appropri
immunogen
stabl
compon
microbiota
edibl
probiot
bacteria
genet
modifi
food
transgen
plant
tokuhara
et
al
howev
caution
must
exercis
vaccin
design
evalu
avoid
induct
mucos
toler
result
prolong
antigen
stimul
yin
yang
mucos
vaccin
immun
versu
toler
discuss
earlier
induct
mucos
iga
respons
involv
multipl
regulatori
mechan
also
function
promot
mucos
system
cell
hyporespons
induc
treg
cell
develop
inde
administr
antigen
human
gastrointestin
respiratori
tract
induc
profound
reduct
cellular
immun
evidenc
diminish
delay
type
hypersensit
reaction
reduc
cell
prolifer
increas
cell
secret
immunosuppress
cytokin
without
alter
humor
immun
mayer
shao
mowat
phenomenon
term
oral
toler
remain
challeng
mucos
vaccin
develop
past
mucos
immun
protocol
elicit
concomit
induct
b
cell
treg
cell
respons
exploit
develop
antibodymedi
protect
polioviru
influenza
viru
bergerot
et
al
phipp
et
al
tamura
et
al
tarkowski
et
al
similar
approach
could
har
dampen
inflammatori
system
mucos
respons
present
disord
asthma
uveiti
diabet
rheumatoid
arthriti
mayer
shao
may
hurdl
mucos
vaccin
pathogen
requir
develop
humor
cellular
immun
respons
system
mucos
site
entri
figur
case
approach
combin
mucos
system
vaccin
one
target
addit
immun
cell
type
less
regulatori
function
h
ctlactiv
abil
neutrophil
appelberg
lp
mononuclear
phagocyt
kamada
et
al
may
effect
studi
base
variou
mous
model
human
diseas
success
exampl
mucos
vaccin
clearli
demonstr
pivot
role
mucos
antibodi
frontlin
immun
protect
instruct
function
system
immun
spite
recent
advanc
structur
biolog
nanotechnolog
improv
vaccin
deliveri
chadwick
et
al
addit
advanc
genom
sequenc
technolog
foster
revers
vaccinolog
antigen
discoveri
see
review
sett
rappuoli
develop
effect
mucos
vaccin
adjuv
still
hamper
inabl
fulli
understand
intric
regulatori
network
govern
mucos
immun
better
understand
network
would
permit
elicit
sustain
protect
immun
respons
mucos
system
district
without
caus
excess
immun
activ
inappropri
immun
toler
current
knowledg
intricaci
character
mucos
immun
system
may
allow
us
glimps
tip
iceberg
lineag
function
heterogen
plastic
mucos
immun
cell
type
review
may
alreadi
seem
exceedingli
confus
geissmann
et
al
yet
mucos
cell
type
key
regulatori
function
describ
buonocor
et
al
dardalhon
et
al
neill
et
al
saenz
et
al
siddiqui
et
al
veldhoen
et
al
addit
function
old
cell
type
molecul
abund
mucos
district
eosinophil
mast
cell
mucin
secretori
compon
antimicrobi
peptid
well
dietderiv
molecul
remain
poorli
understood
tri
take
advantag
regulatori
mechan
vaccin
also
import
bear
mind
sophist
pathogen
hitch
ride
certain
regulatori
mechan
establish
reinforc
infect
fontenot
et
al
addit
mucos
iga
respons
induc
har
regulatori
mechan
result
selflimit
situat
shield
induct
lymphoid
structur
pp
brandtzaeg
johansen
sever
point
immunologist
vaccin
develop
ponder
although
mucos
immun
elicit
mucos
system
antibodi
respons
impact
cellmedi
immun
particularli
induct
system
mucos
ctl
respons
adequ
investig
studi
particularli
relev
design
prophylact
vaccin
pathogen
hiv
might
take
advantag
undesir
effect
diminish
benefici
ctl
respons
spread
higher
speed
throughout
bodi
furthermor
mucos
immun
system
declin
subject
becom
older
phenomenon
call
immunosenesc
galt
declin
earlier
age
nalt
evidenc
reduct
galt
mass
intestin
antigenspecif
iga
respons
defect
oral
toler
induct
fujihashi
kiyono
may
necessit
vaccin
strategi
differ
older
peopl
compar
younger
peopl
suggest
nasal
rout
may
desir
effect
mucos
vaccin
elderli
mucos
immun
system
also
chang
certain
physiolog
patholog
condit
femal
menstrual
cycl
metabol
syndrom
black
et
al
vijaykumar
et
al
affect
outcom
mucos
vaccin
solv
variou
issu
necessari
prerequisit
reach
mileston
vaccin
truli
realiz
aspir
set
forth
millennium
develop
goal
intestin
ec
releas
immun
regulatori
factor
tslp
ra
upon
sens
antigen
lumen
immun
mediat
condit
dc
gener
dc
tipdc
regulatori
dc
produc
immun
regulatori
factor
ra
reinforc
mucos
homeostasi
toler
promot
develop
iga
respons
regulatori
cell
respons
includ
treg
respons
treg
cell
suppress
mucos
system
respons
h
cell
h
cell
ctl
situat
may
repres
challeng
mucos
vaccin
aim
elicit
mucos
system
cellmedi
immun
